Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Knee Surgery Implants now under Price Ceiling, Effective Immediately

      Knee Surgery Implants now under Price Ceiling, Effective Immediately

      supriya kashyap kashyap18 Aug 2017 9:33 AM IST
      New Delhi : Just a day after the Prime Minister, in his independence day address was seen promising that he will bring down the price of knee...
      Not Just Knee Implants, bring down total procedure cost by hospitals too, demands AiMeD

      Not Just Knee Implants, bring down total procedure cost by hospitals too, demands AiMeD

      supriya kashyap kashyap17 Aug 2017 12:14 PM IST
      New Delhi: Domestic medical devices makers body AiMeD welcomed the governments move to cap knee implant prices but said without a reduction in total...
      Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments

      Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments

      supriya kashyap kashyap17 Aug 2017 12:09 PM IST
      New Delhi : Johnson & Johnson Private Limited today announced a new partnership with the Institute of Microbial Technology (IMTECH), part of the...
      Care24 targets to train 10,000 certified healthcare attendants

      Care24 targets to train 10,000 certified healthcare attendants

      supriya kashyap kashyap17 Aug 2017 12:08 PM IST
      Mumbai - Care24, a start-up in the home healthcare sector, on Wednesday said it aims to train up to 10,000 certified healthcare attendants by the end...
      Glenmark Pharma gets USFDA nod for hypertension medicine

      Glenmark Pharma gets USFDA nod for hypertension medicine

      supriya kashyap kashyap9 July 2017 10:16 AM IST
      New Delhi : Glenmark Pharmaceuticals has received final approval from the US health regulator for Amlodipine and Olmesartan Medoxomil tablets, used in...
      Sun Pharma enters into settlement with Certain complainants in Antitrust Litigation Matter

      Sun Pharma enters into settlement with Certain complainants in Antitrust Litigation Matter

      supriya kashyap kashyap9 July 2017 9:30 AM IST
      New Delhi : Sun Pharmaceutical Industries said the company and its arm entered into settlements with certain plaintiffs in an antitrust litigation...
      Lupin pushes Nifty Pharma index higher by 1 percent

      Lupin pushes Nifty Pharma index higher by 1 percent

      supriya kashyap kashyap9 July 2017 9:16 AM IST
      Mumbai : Pharma major, Lupin Limited during morning’s trade was rallying on the bourses, helping the Nifty Pharma to gain over 1 percent in the...
      UK Supreme Court rules in favor of Lilly

      UK Supreme Court rules in favor of Lilly's Alimta patents

      supriya kashyap kashyap8 July 2017 1:15 PM IST
      Eli Lilly and Co won a years-long patent dispute with Actavis after the UK Supreme Court ruled that the generic drug maker's versions of Lilly's...
      Bristol-Myers Squibb’s ORENCIA Receives FDA Approval for Treatment of Active Psoriatic Arthritis

      Bristol-Myers Squibb’s ORENCIA Receives FDA Approval for Treatment of Active Psoriatic Arthritis

      supriya kashyap kashyap8 July 2017 9:16 AM IST
      Princeton : Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration (FDA) has approved ORENCIA for the treatment of adults with...
      FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients

      FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients

      supriya kashyap kashyap27 Jun 2017 12:48 PM IST
      The U.S. Food and Drug Administration approved betrixaban (BEVYXXA, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients...
      Replacing Obamacare by new law in US risk to biz: Dr Reddys

      Replacing Obamacare by new law in US risk to biz: Dr Reddy's

      supriya kashyap kashyap27 Jun 2017 12:46 PM IST
      New Delhi : Homegrown pharma major Dr Reddy's believes that replacing 'Obamacare' by another law in the US will pose risk to its business that can...
      Merck patents on Hepatitis C treatment found valid in Gilead dispute

      Merck patents on Hepatitis C treatment found valid in Gilead dispute

      supriya kashyap kashyap26 Jun 2017 11:30 AM IST
      SAN JOSE : Merck & Co told a federal jury it was seeking more than $2 billion in damages from rival Gilead Sciences Inc after the jury upheld the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok